These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 19152451)

  • 21. Steatosis and progression of fibrosis in untreated patients with chronic hepatitis C infection.
    Perumalswami P; Kleiner DE; Lutchman G; Heller T; Borg B; Park Y; Liang TJ; Hoofnagle JH; Ghany MG
    Hepatology; 2006 Apr; 43(4):780-7. PubMed ID: 16557550
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Abnormal liver function test results are related to metabolic syndrome and BMI in Taiwanese adults without chronic hepatitis B or C.
    Hsieh MH; Ho CK; Hou NJ; Hsieh MY; Lin WY; Yang JF; Chiu CC; Huang JF; Chang NC; Wang CL; Dai CY; Chuang WL; Yu ML
    Int J Obes (Lond); 2009 Nov; 33(11):1309-17. PubMed ID: 19752878
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Study on the relationship between insulin growth factor 1 and liver fibrosis in patients with chronic hepatitis C with type 2 diabetes mellitus.
    Cao LH; Lu FM; Lu XJ; Zhu LY
    J Cell Biochem; 2018 Nov; 119(11):9513-9518. PubMed ID: 30105830
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Associated Factors for Metabolic Syndrome in the Older Adults with Chronic Virus Hepatitis in the Community.
    Kuo YH; Tsai MC; Kee KM; Chang KC; Wang JH; Lin CY; Lin SC; Lu SN
    PLoS One; 2016; 11(5):e0155544. PubMed ID: 27177024
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Hepatic steatosis and fibrosis in young men with treatment-naïve chronic hepatitis B.
    Yun JW; Cho YK; Park JH; Kim HJ; Park DI; Sohn CI; Jeon WK; Kim BI; Son BH; Shin JH
    Liver Int; 2009 Jul; 29(6):878-83. PubMed ID: 19192167
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Hepatic iron accumulation is associated with disease progression and resistance to interferon/ribavirin combination therapy in chronic hepatitis C.
    Fujita N; Sugimoto R; Urawa N; Araki J; Mifuji R; Yamamoto M; Horiike S; Tanaka H; Iwasa M; Kobayashi Y; Adachi Y; Kaito M
    J Gastroenterol Hepatol; 2007 Nov; 22(11):1886-93. PubMed ID: 17914965
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Fibrosis is not just fibrosis - basement membrane modelling and collagen metabolism differs between hepatitis B- and C-induced injury.
    Nielsen MJ; Karsdal MA; Kazankov K; Grønbaek H; Krag A; Leeming DJ; Schuppan D; George J
    Aliment Pharmacol Ther; 2016 Dec; 44(11-12):1242-1252. PubMed ID: 27696451
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Predictive value of the fibrosis scores in patients with chronic hepatitis C associated with liver fibrosis and metabolic syndrome.
    Miyaaki H; Ichikawa T; Taura N; Miuma S; Shibata H; Isomoto H; Takeshima F; Nakao K
    Intern Med; 2011; 50(11):1137-41. PubMed ID: 21628926
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Genotype-specific mechanisms for hepatic steatosis in chronic hepatitis C infection.
    Hui JM; Kench J; Farrell GC; Lin R; Samarasinghe D; Liddle C; Byth K; George J
    J Gastroenterol Hepatol; 2002 Aug; 17(8):873-81. PubMed ID: 12164963
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Impact of steatosis on insulin secretion in chronic hepatitis C patients.
    Narita R; Abe S; Tabaru A; Otsuki M
    Am J Gastroenterol; 2007 Oct; 102(10):2173-80. PubMed ID: 17680843
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Serum adipokine levels in chronic liver diseases: association of resistin levels with fibrosis severity.
    Tsochatzis E; Papatheodoridis GV; Hadziyannis E; Georgiou A; Kafiri G; Tiniakos DG; Manesis EK; Archimandritis AJ
    Scand J Gastroenterol; 2008; 43(9):1128-36. PubMed ID: 18609175
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Retrospective evaluation of serum markers APRI and AST/ALT for assessing liver fibrosis and cirrhosis in chronic hepatitis B and C patients with hepatocellular carcinoma.
    Lin CS; Chang CS; Yang SS; Yeh HZ; Lin CW
    Intern Med; 2008; 47(7):569-75. PubMed ID: 18379139
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Chronic hepatitis B and C in renal graft recipients].
    Zubkin ML; Balakirev EM; Chervinko VI; Zolotarevskiĭ VB; Baranova FS; Taranov VA; Bakulin IG; Stanke AA; Evseev AA; Novozhenov VG
    Vestn Ross Akad Med Nauk; 2006; (11):49-52. PubMed ID: 17136855
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Significance of biglycan and osteopontin as non-invasive markers of liver fibrosis in patients with chronic hepatitis B virus and chronic hepatitis C virus.
    Sobhy A; Fakhry M M; A Azeem H; Ashmawy AM; Omar Khalifa H
    J Investig Med; 2019 Mar; 67(3):681-685. PubMed ID: 30385593
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The validity of serum markers for fibrosis staging in chronic hepatitis B and C.
    Li J; Gordon SC; Rupp LB; Zhang T; Boscarino JA; Vijayadeva V; Schmidt MA; Lu M;
    J Viral Hepat; 2014 Dec; 21(12):930-7. PubMed ID: 24472062
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Hepatic steatosis: prevalence and host/viral risk factors in Iranian patients with chronic hepatitis B infection.
    Poortahmasebi V; Alavian SM; Keyvani H; Norouzi M; Mahmoodi M; Jazayeri SM
    Asian Pac J Cancer Prev; 2014; 15(9):3879-84. PubMed ID: 24935567
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Elevated body mass index is a risk factor associated with possible liver cirrhosis across different etiologies of chronic liver disease.
    Yen YH; Chang KC; Tsai MC; Tseng PL; Lin MT; Wu CK; Lin JT; Hu TH; Wang JH; Chen CH
    J Formos Med Assoc; 2018 Apr; 117(4):268-275. PubMed ID: 28947134
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Metabolic syndrome and liver steatosis occur at lower body mass index in US Asian patients with chronic hepatitis B.
    Clarke WT; Miranda J; Neidich E; Hudock R; Peters MG; Kelly EM
    J Viral Hepat; 2019 Oct; 26(10):1164-1169. PubMed ID: 31134715
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Analysis of clinical and pathological features of chronic hepatitis B with hepatic steatosis].
    Mi YQ; Liu YG; Xu L; Fan JG; Zhang H; Ping L; Shi RF
    Zhonghua Gan Zang Bing Za Zhi; 2009 Nov; 17(11):817-20. PubMed ID: 19958639
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Insulin resistance and diabetes increase fibrosis in the liver of patients with genotype 1 HCV infection.
    Petta S; Cammà C; Di Marco V; Alessi N; Cabibi D; Caldarella R; Licata A; Massenti F; Tarantino G; Marchesini G; Craxì A
    Am J Gastroenterol; 2008 May; 103(5):1136-44. PubMed ID: 18477344
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.